Royce & Associates LP Lantheus Holdings, Inc. Transaction History

Royce & Associates LP

$10.5 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 07, 2023	SELL	$82.41 - $99.65 $2.55 Million - $3.09 Million	-31,000 Reduced 23.34%	101,800 $8.54 Million
Q1 2023 May 04, 2023	BUY	$47.76 - $82.86 $573,120 - $994,320	12,000 Added 9.93%	132,800 $11 Million
Q4 2022 May 23, 2023	SELL	$48.76 - $77.67 $585,120 - $932,040	-12,000 Reduced 9.04%	120,800 $6.16 Million
Q4 2022 Feb 13, 2023	SELL	$48.76 - $77.67 $243,800 - $388,350	-5,000 Reduced 3.97%	120,800 $6.16 Million
Q2 2022 Aug 04, 2022	BUY	$55.54 - $72.65 $1.22 Million - $1.6 Million	22,000 Added 21.19%	125,800 $8.31 Million
Q1 2022 May 05, 2022	BUY	$24.28 - $56.64 $2.52 Million - $5.88 Million	103,800 New	103,800 $5.74 Million
Q3 2020 Nov 12, 2020	SELL	$11.98 - $16.34 $28,332 - $38,644	-2,365 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$10.34 - $15.51 $2,223 - $3,334	215 Added 10.0%	2,365 $34,000
Q1 2020 May 12, 2020	BUY	$9.11 - $20.05 $3,926 - $8,641	431 Added 25.07%	2,150 $27,000
Q4 2019 Feb 06, 2020	SELL	$18.47 - $24.03 $3.44 Million - $4.48 Million	-186,315 Reduced 99.09%	1,719 $35,000
Q3 2019 Nov 13, 2019	SELL	$21.01 - $28.94 $30,464 - $41,963	-1,450 Reduced 0.77%	188,034 $4.71 Million
Q2 2019 Aug 12, 2019	SELL	$23.33 - $28.3 $411,307 - $498,929	-17,630 Reduced 8.51%	189,484 $5.36 Million
Q1 2019 May 09, 2019	SELL	$14.93 - $25.1 $1.4 Million - $2.35 Million	-93,606 Reduced 31.13%	207,114 $5.07 Million
Q4 2018 Feb 11, 2019	SELL	$12.68 - $19.01 $156,521 - $234,659	-12,344 Reduced 3.94%	300,720 $4.71 Million
Q3 2018 Nov 13, 2018	BUY	$13.1 - $16.35 $1.3 Million - $1.62 Million	98,945 Added 46.21%	313,064 $4.68 Million
Q2 2018 Aug 09, 2018	BUY	$13.65 - $18.7 $121,539 - $166,504	8,904 Added 4.34%	214,119 $3.12 Million
Q1 2018 May 14, 2018	BUY	$14.85 - $24.3 $1.23 Million - $2.01 Million	82,599 Added 67.36%	205,215 $3.26 Million
Q4 2017 Feb 09, 2018	SELL	$17.4 - $23.4 $1.4 Million - $1.88 Million	-80,552 Reduced 39.65%	122,616 $2.51 Million
Q3 2017 Nov 13, 2017	SELL	$15.5 - $19.15 $1.15 Million - $1.42 Million	-74,214 Reduced 26.76%	203,168 $3.62 Million
Q2 2017 Aug 07, 2017	BUY	N/A	277,382	277,382 $4.9 Million

Others Institutions Holding LNTH

# of Institutions

540

Shares Held

68M

Call Options Held

679K

Put Options Held

423K

Black Rock Inc. New York, NY

8.6M
Shares

$824 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

7.42M
Shares

$711 Million
0.01% of portfolio
Janus Henderson Group PLC London, X0

3.59M
Shares

$344 Million
0.21% of portfolio
Farallon Capital Management LLC San Francisco, CA

2.96M
Shares

$283 Million
1.63% of portfolio
State Street Corp Boston, MA

2.52M
Shares

$242 Million
0.01% of portfolio

View Full List

About Lantheus Holdings, Inc.

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6.59B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

More about LNTH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Royce & Associates LP with notifications on news.

Account